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Abstract
Background: Coeliac disease in adolescents has been associated with an increased prevalence of
depressive and disruptive behavioural disorders, particularly in the phase before diet treatment.
We studied the possible effects of a gluten-free diet on psychiatric symptoms, on hormonal status
(prolactin, thyroidal function) and on large neutral amino acid serum concentrations in adolescents
with coeliac disease commencing a gluten-free diet.
Methods: Nine adolescents with celiac disease, aged 12 to 16 years, were assessed using the semi-
structured K-SADS-Present and Lifetime Diagnostic interview and several symptom scales. Seven
of them were followed at 1 to 2, 3, and 6 months on a gluten-free diet.
Results: Adolescent coeliac disease patients with depression had significantly lower pre-diet
tryptophan/ competing amino-acid (CAA) ratios and free tryptophan concentrations, and
significantly higher biopsy morning prolactin levels compared to those without depression. A
significant decrease in psychiatric symptoms was found at 3 months on a gluten-free diet compared
to patients' baseline condition, coinciding with significantly decreased coeliac disease activity and
prolactin levels and with a significant increase in serum concentrations of CAAs.
Conclusion: Although our results of the amino acid analysis and prolactin levels in adolescents are
only preliminary, they give support to previous findings on patients with coeliac disease, suggesting
that serotonergic dysfunction due to impaired availability of tryptophan may play a role in
vulnerability to depressive and behavioural disorders also among adolescents with untreated
coeliac disease.
Background
Coeliac disease is an under-diagnosed autoimmune type
of gastrointestinal disorder resulting from gluten inges-
tion in genetically susceptible individuals. Non-specific
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the disease may also be clinically silent. Diagnosis is based
on small-bowel biopsy, and a permanent gluten-free diet
is the essential treatment. Undetected or neglected, coeliac
disease is associated with serious complications. [1-3]
Depressive symptoms [4,5] and disorders [6] are common
among adult patients with coeliac disease, and depressive
and disruptive behavioural disorders are highly common
also among adolescents, particularly in the phase before
diet treatment [7]. Recently 73% of patients with
untreated coeliac disease – but only 7% of patients adher-
ing to a gluten-free diet – were reported to have cerebral
blood flow abnormalities similar to those among patients
with depressive disorders [8].
Improvement in state anxiety [5], in behavioural symp-
toms [9], and in depressive disorders [6,10] may occur
after the start of a standard gluten-free diet, and after a
vitamin B-6-supplemented gluten-free diet [11]. In some
cases, however, the more serious depressive episodes have
appeared following the commencement of a gluten-free
diet [6]. Mechanisms involved have remained unclear.
Some studies have suggested the possibility of impaired
availability of tryptophan and disturbances in central ser-
otonergic function as playing a role [9,12]. In parallel with
this, a significant increase in major serotonin and
dopamine metabolite concentrations in the brain has
been reported after one year on a gluten-free diet [13].
The present work is a preliminary prospective psychiatric
follow-up study of adolescents with newly diagnosed coe-
liac disease measuring psychiatric symptoms, hormonal
status (prolactin, thyroidal function), and large neutral
amino acid (LNAA) serum concentrations repeatedly after
their commencement of a gluten-free diet, testing the
hypothesis that the treatment of coeliac disease may




The study sample comprised all nine adolescents (5 girls,
4 boys; aged 14.6 ± 0.8) consecutively diagnosed with
coeliac disease between January 1999 and December
2000 in the Department of the Gastrointestinal Services of
the Hospital for Children and Adolescents, Helsinki Uni-
versity Central Hospital, in Finland. None of the patients
had a history of, or current psychiatric treatment. Dura-
tion of coeliac disease symptoms and signs (abdominal
pain, diarrhoea, anaemia) leading to a biopsy was 2.3 (±
1.5) years. The study was approved by the institutional
Ethics Committee. Written informed consent was
obtained from each patient and a parent.
Evaluation
Baseline psychiatric evaluation was conducted 1 to 4
weeks after the diagnostic biopsy, during the wait for the
diagnosis of coeliac disease to be established by the
pathologist. The adolescent and a parent were interviewed
separately by an adolescent psychiatrist (PP) using a semi-
structured diagnostic interview, the Schedule for Affective
Disorders and Schizophrenia for School-Age Children –
Present and Lifetime version (K-SADS-PL) [14]. Seven
patients attended the follow-up visits with laboratory tests
at > 1 to ≤ 2, 3, and 6 months after starting a gluten-free
diet (Table 1). Baseline and follow-up behavioural prob-
lems were assessed with the Youth Self Report (YSR) [15]
and the Child Behavior Checklist (CBCL) [16], completed
by a parent (Table 1), and depressive and anxiety symp-
toms by the 21-item versions of the Beck Depression
Inventory (BDI) and Beck Anxiety Inventory (BAI), the
17-item version of the Hamilton Depression Rating Scale
(HAM-D), and the 14-item Hamilton Anxiety Rating Scale
(HAM-A). CGAS (Children's Global Assessment) served
as a part of the K-SADS-PL.
Coeliac disease activity was followed by determining
serum tissue transglutaminase (S-tTGAbA) and endomy-
sium (S-EndoAbA) autoantibodies [17]. Pre-diet blood
samples for analysis of amino acids, prolactin, thyroid
function [thyroxine (S-T4), thyroid-stimulating hormone
(TSH)], vitamins B6 and B12, S-tTGAbA, and S-EndoAbA
were obtained on the biopsy morning, and subsequent
ones as a part of follow-up visits, both after overnight fast-
ing, between 8 and 10 a.m. All nine patients had amino
acid concentrations measured at baseline, and five of
them during follow-up (1–2 times). A blood sample (2
ml) was drawn from the ulnar vein into a vacuum tube for
serum total and free L-tryptophan, and for other large
neutral amino acids (LNAA). The tube was cooled imme-
diately and stored refrigerated in ice until centrifuged.
After centrifugation, the serum was frozen and stored at -
20°C for 4 to 14 months (median 7.5) until its assay for
the amino acids by a modified procedure described by
Qureshi et al. [18]. All the samples were analysed in a sin-
gle run, in Kuopio, Finland, and free and total L-tryp-
tophan and other LNAA's were assessed as described by
Tiihonen et al. [19].
Statistical methods
Statistical analysis was carried out with parametric and
non-parametric tests as appropriate; tests for two-inde-
pendent groups (T-test, Mann-Whitney U-test), for
repeated measures of two-related groups (Wilcoxon
signed-ranks test), for three-related groups (Friedman
test) and Spearman's rank correlation testing were used. P-
values (2-tailed) < 0.05 were regarded as significant.Page 2 of 6
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Baseline evaluation
At baseline, three adolescents (3/9; 33%) had a depressive
disorder: two girls had major depressive disorder (MDD),
one with a learning disorder not otherwise specified
(NOS), and another with comorbid conduct disorder; one
girl had the depressive disorder NOS. Further, one boy
had a phobic disorder plus attention-deficit hyperactivity
disorder, and another conduct disorder NOS. Four adoles-
cents (44%) had no diagnosis.
Pre-diet free L-tryptophan was positively correlated with
pre-diet levels of tTGAbA (n = 8; r = 0.78, P= 0.022), and
negatively with vitamin B-6 (r = 0.73, P = 0.039) and S-T4
(r = 0.74, P = 0.035). Prolactin levels (Table 1) from the
biopsy morning showed a positive correlation with BDI
score (self-report depression inventory; r = 0.89, P =
0.001), and a negative correlation with the ratio of L-tryp-
tophan to amino acids competing for the same cerebral
uptake mechanism (CAA) (r = 0.68, P = 0.042), but not
with free L-tryptophan levels. The sum of branched-chain
amino acids (BCAA: valine, leucine, and isoleucine)
showed no correlation with L-tryptophan or free L-tryp-
tophan levels.
Depressive patients (n = 3/9) had significantly higher pre-
diet prolactin levels (mU/l: mean ± S.D. = 2450 ± 676 vs.
1194 ± 598, Mann-Whitney U-test, P = 0.039) and pre-
diet S-T4 levels (nmol/l: mean 102 ± 3.1 vs. 84 ± 16.1,
Mann-Whitney U-test, P = 0.024), and significantly lower
L-tryptophan/CAA ratios (100 × pmol/µl: pmol/µl: mean
10.0 ± 0.2 vs. 11.5 ± 1.7, Mann-Whitney U-test, P = 0.020)
and free L-tryptophan concentrations (pmol/µl: mean 4.7
± 0.5 vs. 8.4 ± 3.0, two-independent samples T-test, P =
0.029). Pre-diet free L-tryptophan correlated negatively
with biopsy morning S-T4 level (r = -0.74, P = 0.035). No
significant differences appeared in L-tryptophan (36.3 ±
5.1 vs. 43.3 ± 6.1) or in L-tyrosine concentrations, nor in
BCAA and CAA levels.
Follow-up
Two adolescents with conduct disorders, one a girl with
concomitant MDD, did not adhere to the gluten-free diet
and dropped out of the psychiatric follow-up. Among oth-
ers (n = 7), a significant decrease in most of the problem
and symptom scores of YSR and CBCL, and in BDI, BAI,
and Hamilton scales was evident after 3 months on the
gluten-free diet, compared to baseline (Table 1).
Celiac disease-associated antibody titres had decreased in
all by the first month on a gluten-free diet, and had
already normalised (= S-EndoAbA titre < 5 and S-tTGAbA
titre < 8) in 4 of 7 patients by 6 months. Boys had lower
biopsy morning prolactin levels (mU/l; mean 972, SD
450 vs. girls mean 2126 ± 756; one-way Anova P = 0.032),
but higher levels after one month on the diet. In the first
month, the S-T4/TSH ratio (nmol/l:mU/l) reflecting thy-
roid function increased significantly (Table 1).
Table 1: Psychiatric symptoms and disease activity among adolescent CD patients (n = 7, mean ± SD)
0 (baseline) 1–2 months p-value1) 3 months p-value1) 6 months p-value2)
CGAS 3) 74.4 (± 16.5)4) 86.9 (± 5.6) 0.043 88.3 (± 9.2) 0.006
HAM-D5) 5.7 (± 7.3) 0.3 (± 0.8) 0.043 1.0 (± 1.3) 0.009
HAM-A6) 6.9 (± 6.9) 0.1 (± 0.4) 0.043 0.7 (± 1.3) 0.010
BDI7) 3.4 (± 6.5) 0.0 (± 0.0) 8) n.s.9) 0.1 (± 0.4) 0.041 0.6 (± 1.1) 0.014
BAI10) 3.0 (± 2.9) 1.3 (± 1.5) 8) n.s. 0.7 (± 1.1) 0.042 1.4 (± 2.2) n.s.
CBCL11) Total problems 28.3 (± 12.8) 18.4 (± 6.9) 0.028 14.0 (± 9.5) 0.028 18.4 (± 16.2) 0.007
Anxious/depressed 3.9 (± 3.1) 1.4 (± 1.7) 0.046 1.3 (± 1.5) 0.026 1.3 (± 1.1) 0.033
Aggressive behaviour 7.3 (± 4.2) 5.6 (± 2.2) n.s. 3.6 (± 3.1) 0.039 6.0 (± 6.4) 0.047
YSR12) Total problems 24.4 (± 13.8) 17.0 (± 12.5) n.s. 8.0 (± 7.8) 0.018 9.4 (± 7.4) 0.001
Anxious/depressed 2.7 (± 3.4) 1.6 (± 2.2) n.s. 0.3 (± 0.5) 0.026 0.6 (± 1.0) 0.002
Aggressive behaviour 5.1 (± 2.7) 4.1 (± 2.7) n.s. 2.0 (± 2.2) 0.044 2.4 (± 1.4) 0.021
Somatic complains 4.9 (± 2.4) 3.1 (± 2.3) 0.038 2.1 (± 1.2) 0.026 2.3 (± 2.1) 0.003
S-EndoAbA8) 800(200–
1600)
200 (5–400) 0.018 5 (5–1600) 0.027 5 (5–100) 0.001
S-tTGAbA 139 (± 158) 30 (± 35) 0.018 19 (± 26) 0.018 7 (± 8) < 0.001
Prolactin (mU/l)13) 1569 (± 767) 218 (± 60) 0.028 284 (± 170) 0.018 205 (± 92)14) 0.019
S-T4/TSH (nmol/l:mU/l) 34 (± 6) 64 (± 38)14) 0.043 84 (± 53) 0.043 74 (± 32)15) 0.039
1) non-parametric Wilcoxon signed-ranks test; compared with baseline; 2) repeated measures non-parametric Friedman test; 3) Children's Global 
Assessment; 4) mean ± SD; 5) Hamilton Depression Rating Scale; 6) Hamilton Anxiety Rating Scale ; 7) Beck Depression Inventory; 8) median (min-
max); 9) non significant; 10) Beck Anxiety Inventory; 11) Child Behavior Checklist; 12) Youth Self Report; 13) normal: females 50–300, males 50–500; 14) 
n = 6 ; 15) n = 4Page 3 of 6
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total and free L-tryptophan was reaching significance after
one month on a gluten-free diet. By 3 months, the
increases in tyrosine alone and in CAAs as a group were
significant, and the increase in free L-tryptophan was
approaching significance (repeated measures Friedman
test n = 4, Chi-Square 6,000, df 2, P = 0.050). (Table 2)
Discussion
We observed that the majority of adolescents with coeliac
disease had depressive and behavioural symptoms before
their diagnosis, and that coeliac disease patients with
depression (all girls) had significantly lower pre-diet tryp-
tophan/CAA ratios and free tryptophan concentrations
and significantly higher biopsy morning prolactin levels.
Adolescents with coeliac disease showed improvement in
psychiatric symptoms after starting a gluten-free diet, and
this improvement coincided with a significant decrease in
coeliac disease activity and in prolactin levels, and with a
significant increase in serum concentrations of L-tyrosine
and other CAAs. The increase in free L-tryptophan levels
was approaching significance. The findings of this study –
improvement in depressive and behavioural symptoms
after the start of a gluten-free diet – are supported by the
findings of our larger previous retrospective case-control
study [7]. Although the results of the amino acid analysis
and prolactin levels are only preliminary, they give sup-
port to the hypothesis that impaired availability of tryp-
tophan and the possible consequent serotonergic
dysfunction may play a role in vulnerability to depressive
disorders among adolescents with untreated coeliac dis-
ease. A possible role for tyrosine and the brain's catecho-
lamine metabolism (dopamine and noradrenaline) in
these disorders cannot, however, be excluded.
The decrease observed in psychiatric symptoms took place
regardless of the stress accompanying being diagnosed
with a chronic and restrictive illness, and improvement
was not explainable in terms of physical symptoms, since
both in the present and in our previous study [7], the pres-
ence or alleviation of depression showed no association
with somatic symptom severity. Our results from adoles-
cents differ from those reported by Addolorato et al. [5].
In their follow-up study on adult patients with coeliac dis-
ease, a significant decrease in anxiety symptoms but not in
depressive symptoms appeared after one year on a gluten-
free diet. Although converging with the findings of Ljung-
man and Myrdal (20), the few symptoms of our adoles-
cents with coeliac disease adhering to a gluten-free diet in
our present and previous [7] studies are thus in contrast to
the findings of depressive symptoms [4,5] and disorders
[6] as being common among adult patients with coeliac
disease, even during diet treatment.
Since the free tryptophan and the tryptophan/CAA ratios
in plasma determine the availability of tryptophan to the
brain [21], our findings on depressive patients give pre-
liminary support to suggestions of impaired availability of
tryptophan as featuring in coeliac-associated depressive
and behavioural disorders associated with celiac disease
[9,12,13]. As we did not have a control group of healthy
adolescents, we cannot say whether L-tryptophan or L-
tyrosine levels or both are generally lower among adoles-
cents with coeliac disease, as could be expected based on
the findings of Hernanz and Polanco [9], who reported
significantly decreased plasma tryptophan and tyrosine
concentrations in untreated and treated children with coe-
liac disease compared to levels in controls.
In the present study, stress-induced biopsy-morning prol-
actin levels were significantly higher among depressive
patients (all girls) and correlated negatively with L-tryp-
tophan/CAA levels. This finding is only preliminary, but it
is, however, interesting: Although disturbances in the cen-
Table 2: Follow-up of the patients (n = 5): psychiatric symptoms, CD activity, and amino acidconcentrations [median (min-max)].
0 (baseline) ≥1<1.5 months1) p-value2) ≥3 months p-value2)
CBCL Total problems 34 (9–39) 21 (8–29) ** 21 (2–22) **
YSR Total problems 20 (9–36) 11 (5–41) n.s. 2 (0–22) **
S-tTGAbA 42 (10–310) 5 (3–51) ** 3 (1–17) **
Prolactin3) 1100 (635–2850) 256 (127–282) n.s * 244 (110–565) **
L-tyrosine4) 33 (26–44) 39 (37–70) n.s * 40 (38–47) **
CAA5) 353 (316–441) 401 (368–657) n.s * 395 (367–568) **
L-tryptophan4) 40 (32–51) 52 (45–66) n.s * 46 (36–59) n.s.
Tryptophan/CAA6) 11.3 (10.1–14.9) 12.0 (10.1–14.1) n.s. 10.1 (9.5–12.5) n.s.
Free L-tryptophan 4) 4.9 (4.5–11.8) 8.4 (5.3–10.9) n.s * 10.6 (5.0–19.0) n.s. * 7)
Free tryptophan/CAA6) 1.4 (1.0–3.5) 1.9 (1.0–3.0) n.s. 2.6 (1.3–3.4) n.s.
1) amino acid concentrations; n = 4; 2) Wilcoxon signed – ranks test: compared with baseline; ** = P < 0.05; * = P ≥ 0.05 < 0.07; 3) mU/l; normal: 
females 50–300, males 50–500; 4) pmol/µl; 5) L-valine, L-leucine, L-isoleucine, L-phenylalanine, L-tyrosine; pmol/µl; 6) 100 × pmol/µl: pmol/µl; 7) 
repeated Measures Friedman test, n = 4, P = 0.050Page 4 of 6
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sive and impulse-control disorders among adults [see
[22]], and children aged 6 to 12 years with a recent suicide
attempt have shown lower whole blood tryptophan con-
tent [23], serotonergic dysfunction in adolescents with
depression is still poorly studied. The prolactin hyperse-
cretion response to the L-5-hydroxytryptophan challenge
(L-5HTP) test reported among pre-pubertal girls with
major depressive disorder [24] and among healthy chil-
dren at high risk for major depressive disorder (= high
family loading for major depression) [25], may be con-
sistent with dysregulation of the central serotonergic sys-
tem in childhood major depression [24]. Moreover,
alterations in neuroendocrine responses to L-5HTP chal-
lenge tests, such as the prolactin hypersecretion and
hyposecretion of cortisol found in healthy children, have
been suggested to represent a trait marker for depression
in children [25]. Thus, the high biopsy morning prolactin
levels in depressed adolescents with untreated coeliac dis-
ease in the present study could be associated with seroton-
ergic dysfunction. They could also be associated with
dopaminergic dysfunction due to impaired availability of
tyrosine, since dopamine is known to exert an inhibitory
action on prolactin release in the hypothalamus [26]. In
the present study, however, pre-diet prolactin levels did
not correlate with tyrosine levels. Moreover, the function
of the intestinal Catechol-O-Methyl Transferase enzyme
(COMT) – known to play an important role in the periph-
eral O-methylation of catecholamines – remains unstud-
ied in untreated coeliac disease. It is of some theoretical
interest that reduced COMT activity in erythrocytes has at
least once been associated with conditions such as pri-
mary affective disorders in women [27].
On the other hand, in the present study also non-
depressed adolescents with coeliac disease had higher
than normal biopsy morning prolactin levels. Signifi-
cantly higher prolactin levels among untreated coeliac
children (5–18 years) compared with treated patients has
been reported by Reifen et al. [28]. They suggest that pro-
lactin may play a part in the immune modulation of the
intestine and could thus serve as a potential marker for
coeliac disease activity.
Our preliminary findings on amino acid levels in adoles-
cents with coeliac disease with or without depression are
unlikely to be explained by malabsorption, since pre-diet
free L-tryptophan and tryptophan ratios were not corre-
lated with the BCAA levels that reflect the level of protein
nutrition. It is of theoretical interest that increased pro-
duction of interferon-γ (IFN-γ), known to be the predom-
inant cytokine produced by gluten-specific T-cells in
active coeliac disease [29], can suppress serotonin func-
tion both directly and indirectly by enhancing tryptophan
and serotonin turnover [30]. Increased IFN-γ [30] and, for
instance, such events as a stress-related increase in liver
tryptophan pyrrolase enzyme activity [23], may lead to
lowered tryptophan levels by the enhanced tryptophan
catabolism induced by increased activity of the kynure-
nine-niacin pathway [30-32], even without
malabsorption.
Conclusion
The alleviation of psychiatric symptoms found among
adolescents with coeliac disease after commencement of a
gluten-free diet coincides with a rapid decrease in anti-
body titres indicating coeliac disease activity and in their
prolactin levels, and with a significant increase in L-tyro-
sine and other CAA serum concentrations, and with a
nearly significant increase in the free fraction of L-tryp-
tophan. Although these findings are only preliminary,
and more research is needed, they give support to previ-
ous findings on patients with coeliac disease, suggesting
that serotonergic dysfunction due to impaired availability
of tryptophan may play a role in vulnerability to depres-
sive and behavioural disorders, also among adolescents
with untreated celiac disease. And since diet treatment
may alleviate psychiatric symptoms, and earlier diagnosis
may have beneficial effects on psychological and even on
neurobiological vulnerability to depression, the possibil-
ity of psychiatric complications of coeliac disease needs to
be taken into account in differential diagnosis of depres-
sive and behavioural disorders.
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